Unknown NA INTERVENTIONAL 2-arm NCT02933294

Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer

Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer: a Multicenter Randomized Controlled Trial

Sponsor: Beijing Chest Hospital

Conditions Lung Neoplasms

Interventions Triportal pulmonary resection surgery Uniportal pulmonary resection surgery

Updated 5 times since 2017 Last updated: Oct 12, 2016 Started: May 31, 2015 Primary completion: Apr 30, 2018 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02933294, this NA trial focuses on Lung Neoplasms and remains ongoing. Sponsored by Beijing Chest Hospital, it has been updated 5 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2021 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Chest Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Chinese PLA General Hospital
Fudan University
Sun Yat-sen University

Data source: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials